{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T16:18:31Z","timestamp":1784045911517,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000},"content-version":"vor","delay-in-days":2784,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000001","name":"Dept Veterans Affairs","doi-asserted-by":"publisher","award":["ID0E5IAE238"],"award-info":[{"award-number":["ID0E5IAE238"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s13311-015-0404-4","type":"journal-article","created":{"date-parts":[[2015,11,16]],"date-time":"2015-11-16T18:00:54Z","timestamp":1447696854000},"page":"217-225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Neuronal Glutathione Content and Antioxidant Capacity can be Normalized In Situ by N-acetyl Cysteine Concentrations Attained in Human Cerebrospinal Fluid"],"prefix":"10.1016","volume":"13","author":[{"given":"Reno C.","family":"Reyes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giordano Fabricio","family":"Cittolin-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Eun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok Joon","family":"Won","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela M.","family":"Brennan-Minnella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham A.","family":"Glass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond A.","family":"Swanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-015-0404-4_bib1","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/JPD-130230","article-title":"The role of oxidative stress in Parkinson's disease","volume":"3","author":"Dias","year":"2013","journal-title":"J Parkinsons Dis"},{"key":"10.1007\/s13311-015-0404-4_bib2","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.freeradbiomed.2012.09.016","article-title":"Oxidative stress, neurodegeneration, and the balance of protein degradation and protein synthesis","volume":"62","author":"Dasuri","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"10.1007\/s13311-015-0404-4_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.freeradbiomed.2013.05.001","article-title":"Glutathione metabolism and Parkinson's disease","volume":"62","author":"Smeyne","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"10.1007\/s13311-015-0404-4_bib4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0304-3940(82)90390-1","article-title":"Parkinson's disease: a disorder due to nigral glutathione deficiency?","volume":"33","author":"Perry","year":"1982","journal-title":"Neurosci Lett"},{"key":"10.1007\/s13311-015-0404-4_bib5","first-page":"147","article-title":"Nongenetic causes of Parkinson's disease","volume":"70","author":"Chade","year":"2006","journal-title":"J Neural Transm Suppl"},{"key":"10.1007\/s13311-015-0404-4_bib6","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/ana.22162","article-title":"N-acetylcysteine prevents loss of dopaminergic neurons in the EAAC1\u2013\/\u2013 mouse","volume":"69","author":"Berman","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-015-0404-4_bib7","doi-asserted-by":"crossref","first-page":"13997","DOI":"10.1523\/JNEUROSCI.3885-07.2007","article-title":"Inducible alterations of glutathione levels in adult dopaminergic midbrain neurons result in nigrostriatal degeneration","volume":"27","author":"Chinta","year":"2007","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-015-0404-4_bib8","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/00001756-199603220-00018","article-title":"Glutathione depletion potentiates MPTP and MPP+ toxicity in nigral dopaminergic neurones","volume":"7","author":"Wullner","year":"1996","journal-title":"Neuroreport"},{"key":"10.1007\/s13311-015-0404-4_bib9","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.nurt.2008.01.007","article-title":"Protection against Parkinson's disease progression: clinical experience","volume":"5","author":"LeWitt","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1007\/s13311-015-0404-4_bib10","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMoa0809335","article-title":"A double-blind, delayed-start trial of rasagiline in Parkinson's disease","volume":"361","author":"Olanow","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1007\/s13311-015-0404-4_bib11","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.pharmthera.2013.09.006","article-title":"Existing and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefits","volume":"141","author":"Rushworth","year":"2014","journal-title":"Pharmacol Ther"},{"key":"10.1007\/s13311-015-0404-4_bib12","doi-asserted-by":"crossref","first-page":"C849","DOI":"10.1152\/ajpcell.00283.2008","article-title":"Radical-free biology of oxidative stress","volume":"295","author":"Jones","year":"2008","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1007\/s13311-015-0404-4_bib13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mehy.2012.03.021","article-title":"N-acetyl-cysteine in the treatment of Parkinson's disease. What are we waiting for?","volume":"79","author":"Martinez-Banaclocha","year":"2012","journal-title":"Med Hypotheses"},{"key":"10.1007\/s13311-015-0404-4_bib14","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.biopha.2008.01.017","article-title":"Glutathione and Parkinson's disease: is this the elephant in the room?","volume":"62","author":"Zeevalk","year":"2008","journal-title":"Biomed Pharmacother"},{"key":"10.1007\/s13311-015-0404-4_bib15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/WNF.0b013e31829ae713","article-title":"N-Acetylcysteine boosts brain and blood glutathione in Gaucher and Parkinson diseases","volume":"36","author":"Holmay","year":"2013","journal-title":"Clin Neuropharmacol"},{"key":"10.1007\/s13311-015-0404-4_bib16","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.neubiorev.2015.04.015","article-title":"Clinical trials of N-acetylcysteine in psychiatry and neurology: a systematic review","volume":"55","author":"Deepmala","year":"2015","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1007\/s13311-015-0404-4_bib17","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3109\/10715762.2013.781595","article-title":"N-Acetylcysteine amide: a derivative to fulfill the promises of N-Acetylcysteine","volume":"47","author":"Sunitha","year":"2013","journal-title":"Free Radic Res"},{"key":"10.1007\/s13311-015-0404-4_bib18","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0896-6273(00)80958-7","article-title":"Mutant mice and neuroscience: recommendations concerning genetic background. Banbury Conference on genetic background in mice","volume":"19","author":"Banbury Conference","year":"1997","journal-title":"Neuron"},{"key":"10.1007\/s13311-015-0404-4_bib19","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/sj.jcbfm.9600292","article-title":"NAD(P)H fluorescence transients after synaptic activity in brain slices: predominant role of mitochondrial function","volume":"26","author":"Brennan","year":"2006","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1007\/s13311-015-0404-4_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3109\/10715769209061085","article-title":"The simultaneous generation of superoxide and nitric oxide can initiate lipid peroxidation in human low density lipoprotein","volume":"17","author":"Darley-Usmar","year":"1992","journal-title":"Free Radic Res Commun"},{"key":"10.1007\/s13311-015-0404-4_bib21","doi-asserted-by":"crossref","first-page":"7143","DOI":"10.1523\/JNEUROSCI.4826-14.2015","article-title":"Assessment at the single-cell level identifies neuronal glutathione depletion as both a cause and effect of ischemia-reperfusion oxidative stress","volume":"35","author":"Won","year":"2015","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-015-0404-4_bib22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.brainres.2009.04.029","article-title":"Reduced glutathione is highly expressed in white matter and neurons in the unperturbed mouse brain\u2014implications for oxidative stress associated with neurodegeneration","volume":"1276","author":"Miller","year":"2009","journal-title":"Brain Res"},{"key":"10.1007\/s13311-015-0404-4_bib23","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/0003-2697(90)90208-Q","article-title":"Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples","volume":"190","author":"Baker","year":"1990","journal-title":"Anal Biochem"},{"key":"10.1007\/s13311-015-0404-4_bib24","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.parkreldis.2015.02.020","article-title":"Cerebrospinal fluid concentrations of N-acetylcysteine after oral administration in Parkinson's disease","volume":"21","author":"Katz","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1007\/s13311-015-0404-4_bib25","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0891-5849(99)00176-8","article-title":"Biologic and pharmacologic regulation of mammalian glutathione synthesis","volume":"27","author":"Griffith","year":"1999","journal-title":"Free Radic Biol Med"},{"key":"10.1007\/s13311-015-0404-4_bib26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nn1609","article-title":"Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse","volume":"9","author":"Aoyama","year":"2006","journal-title":"Nat Neurosci"},{"key":"10.1007\/s13311-015-0404-4_bib27","doi-asserted-by":"crossref","first-page":"4980","DOI":"10.1021\/bi900030z","article-title":"Glutathione depletion by buthionine sulfoximine induces oxidative damage to DNA in organs of rabbits in vivo","volume":"48","author":"Gokce","year":"2009","journal-title":"Biochemistry"},{"key":"10.1007\/s13311-015-0404-4_bib28","doi-asserted-by":"crossref","first-page":"C1424","DOI":"10.1152\/ajpcell.1996.271.5.C1424","article-title":"Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly","volume":"271","author":"Beckman","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1007\/s13311-015-0404-4_bib29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0891-5849(91)90192-6","article-title":"Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes","volume":"11","author":"Esterbauer","year":"1991","journal-title":"Free Radic Biol Med"},{"key":"10.1007\/s13311-015-0404-4_bib30","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1054\/mehy.2000.1194","article-title":"Therapeutic potential of N-acetylcysteine in age-related mitochondrial neurodegenerative diseases","volume":"56","author":"Banaclocha","year":"2001","journal-title":"Med Hypotheses"},{"key":"10.1007\/s13311-015-0404-4_bib31","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.freeradbiomed.2006.08.002","article-title":"Reversible inhibition of mitochondrial complex I activity following chronic dopaminergic glutathione depletion in vitro: implications for Parkinson's disease","volume":"41","author":"Chinta","year":"2006","journal-title":"Free Radic Biol Med"},{"key":"10.1007\/s13311-015-0404-4_bib32","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.nbd.2012.10.011","article-title":"Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism","volume":"51","author":"Hauser","year":"2013","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-015-0404-4_bib33","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/j.1471-4159.2007.04641.x","article-title":"Mitochondrial glutathione protects against cell death induced by oxidative and nitrative stress in astrocytes","volume":"102","author":"Muyderman","year":"2007","journal-title":"J Neurochem"},{"key":"10.1007\/s13311-015-0404-4_bib34","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0301-0082(99)00060-X","article-title":"Metabolism and functions of glutathione in brain","volume":"62","author":"Dringen","year":"2000","journal-title":"Prog Neurobiol"},{"key":"10.1007\/s13311-015-0404-4_bib35","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/biof.5520170111","article-title":"Multidrug resistance-associated proteins: export pumps for conjugates with glutathione, glucuronate or sulfate","volume":"17","author":"Homolya","year":"2003","journal-title":"Biofactors"},{"key":"10.1007\/s13311-015-0404-4_bib36","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0891-5849(89)90066-X","article-title":"The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid","volume":"6","author":"Aruoma","year":"1989","journal-title":"Free Radic Biol Med"},{"key":"10.1007\/s13311-015-0404-4_bib37","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1093\/jn\/132.11.3369","article-title":"Enzymes and metabolites of cysteine metabolism in nonhepatic tissues of rats show little response to changes in dietary protein or sulfur amino acid levels","volume":"132","author":"Stipanuk","year":"2002","journal-title":"J Nutr"},{"key":"10.1007\/s13311-015-0404-4_bib38","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1002\/jps.23325","article-title":"Interaction of N-acetylcysteine and cysteine in human plasma","volume":"101","author":"Radtke","year":"2012","journal-title":"J Pharm Sci"},{"key":"10.1007\/s13311-015-0404-4_bib39","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1002\/jps.24482","article-title":"Intravenous administration of stable-labeled N-acetylcysteine demonstrates an indirect mechanism for boosting glutathione and improving redox status","volume":"104","author":"Zhou","year":"2015","journal-title":"J Pharm Sci"}],"updated-by":[{"DOI":"10.1007\/s13311-015-0413-3","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000}}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-015-0404-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13311-015-0404-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923009522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923009522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-015-0404-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-015-0404-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T07:11:16Z","timestamp":1704179476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923009522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S1878747923009522"],"URL":"https:\/\/doi.org\/10.1007\/s13311-015-0404-4","relation":{"erratum":[{"id-type":"doi","id":"10.1007\/s13311-015-0413-3","asserted-by":"object"}]},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuronal Glutathione Content and Antioxidant Capacity can be Normalized In Situ by N-acetyl Cysteine Concentrations Attained in Human Cerebrospinal Fluid","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-015-0404-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1007\/s13311-015-0413-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}